Serum neopterin, retinol and alpha-tocopherol in patients with the carcinoma of the esophagus

Pteridines

Volumn 20, Issue 2, 2009, Pages 49-53

  Cincibuch, Jan ^a   Melichar, Bohuslav ^a,b   Študentová, Hana ^a   Kapustová, Miloslava ^a   Malírová, Eva ^b   Solichová, Dagmar ^b   Krcmová, Lenka ^b,c   Kašparová, Markéta ^b,c   Schneiderka, Petr ^a   Juránová, Jarmila ^a   Šrámek, Vlastislav ^a   Cwiertka, Karel ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Alpha tocopherol; Esophageal carcinoma; Neopterin; Retinol

Indexed keywords

ALPHA TOCOPHEROL; CISPLATIN; FLUOROURACIL; HEMOGLOBIN; NEOPTERIN; RETINOL;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; LEUKOCYTE COUNT; LOWER ESOPHAGUS SPHINCTER; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SQUAMOUS CELL CARCINOMA; THROMBOCYTE COUNT;

EID: 69149104122     PISSN: 09334807     EISSN: 21954720     Source Type: Journal    
DOI: 10.1515/pteridines.2009.20.1.49     Document Type: Article

References (18)

1. Enzinger PC, Ilson DH, Kelsen DP. Chemotherapy in esophageal cancer. Semin Oncol 1999; 26 (Suppl. 15): 12-20.
2. Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 1999; 91: 1616-1634.
3. Fuchs D, Hausen A, Reibnegger G, et al. Immune activation and the anaemia associated with chronic inflammatory disorders. Eur J Haematol 1991; 46: 65-70.
4. Denz H, Fuchs D, Huber H, et al. Correlation between neopterin, interferon-gamma and haemoglobin in patients with haematological disorders. Eur J Haematol 1990; 44: 186-189. (Pubitemid 20168504)
5. Wachter H, Artner-Dworzak E, Fuchs D, et al. Association between neopterin and iron metabolism in cancer patients. TumorDiagn Ther 1990; 11: 229-232.
6. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 1989; 27: 81-141.
7. Melichar B, Urbanek L, Krcmova L, et al. Urinary neopterin, hemoglobin and peripheral blood cell counts in breast carcinoma patients treated with dose-dense chemotherapy. Anticancer Res 2008; 28: 2389-2396.
8. Murr C, Fuith LC, Widner B, Wirleitner B, Baier-Bitterlich G, Fuchs D. Increased neopterin concentrations in patients with cancer indicator of oxidative stress? Anticancer Res 1999; 19: 1721-1728.
9. Blaha V, Solichova D, Cernohorsky D, Hyspler R, Zdansky P, Zadak Z. Fluorometric assay of lipoperoxides and chromatographic analysis of alfa tocopherol and fatty acids as biomarkers of risk from coronary atherosclerosis. Talanta 2003; 60: 505-513.
10. Melichar B, Kalabova H, Krcmova L, et al. Serum alpha-tocopherol, retinol and neopterin during paclitaxel/carboplatin chemotherapy. Anticancer Res 2007; 27: 4397-4401.
11. Melichar B, Solichova D, Svobodova I, Urbanek L, Melicharova K. Urinary neopterin in patients with upper gastrointestinal, biliary and pancreatic carcinomas. Pteridines 2006; 17: 20-24.
12. Urbanek L, Solichova D, Melichar B, Dvorak J, Svobodova I, Solich P. Optimization and validation of a high performance liquid chromatography method for the simultaneous determination of vitamins A and E human serum using monolithic column and diode-array detection. Anal Chim Acta 2006; 573-574: 267-272. (Pubitemid 44066934)
13. Melichar B, Solichová D, Freedman RS. Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies. Int J Gynecol Cancer 2006; 16: 240-252.
14. Reibnegger G, Fuchs D, Fuith LC, et al. Neopterin as a marker for activated cell-mediated immunity: application in malignant disease. Cancer Detect Prev 1991; 15: 483-490.
15. Cengiz M, Akbulut S, Atahan IL, Grigsby PW. Acute phase response during radiotherapy. Int J Radiat Oncol Biol Phys 2001; 49: 1093-1096.
16. Guillem P, Triboulet JP. Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer. Dis Esophagus 2005; 18: 146-150. (Pubitemid 41801107)
17. Di Fiore F, Lecleire S, Pop D, et al. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 2007; 102: 2557-2563. (Pubitemid 47631770)
18. Rades D, Schild SE, Bahrehmad R, Zschenker O, Alberti WA, Rudat VR. Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy. Cancer 2005; 103: 1740-1746.